{"acute kidney injury": 2.42, "acute respiratory distress syndrome": 14.73, "alanine aminotransferase increased": 2.41, "aspartate aminotransferase increased": 2.23, "aspergillus infection": 125.3, "blood alkaline phosphatase increased": 9.99, "blood bilirubin increased": 6.2, "bronchopulmonary aspergillosis": 61.44, "candida infection": 42.13, "condition aggravated": 2.66, "cutaneous calcification": 1368.35, "death": 2.88, "disseminated intravascular coagulation": 9.59, "drug ineffective": 10.61, "drug ineffective for unapproved indication": 11.11, "drug interaction": 3.3, "drug resistance": 33.92, "drug-induced liver injury": 7.67, "febrile neutropenia": 2.34, "fungaemia": 296.48, "fungal infection": 29.72, "hepatic enzyme increased": 2.29, "hepatic failure": 6.78, "hepatic function abnormal": 3.08, "hepatotoxicity": 11.75, "hypokalaemia": 9.88, "liver function test abnormal": 5.5, "mucormycosis": 134.24, "multiple organ dysfunction syndrome": 28.41, "pancytopenia": 2.74, "pathogen resistance": 86.91, "pneumonia": 2.01, "product use in unapproved indication": 4.79, "rash maculo-papular": 11.17, "renal failure": 3.2, "renal impairment": 2.63, "respiratory distress": 4.3, "respiratory failure": 6.39, "sepsis": 8.26, "septic shock": 18.43, "systemic candida": 166.16, "systemic mycosis": 75.9, "therapeutic product effect incomplete": 3.73, "therapy non-responder": 13.31, "toxic epidermal necrolysis": 18.63, "transaminases increased": 3.81, "treatment failure": 10.58}